Article

Seattle TimesSeattle Times on 2022-07-20 15:20

Biogen chops expenses in Q2, raises 2022 profit forecast

Cost cutting helped Biogen beat second-quarter expectations soundly even as revenue slid and sales of the drugmaker’s controversial Alzheimer’s ...

Related news